知名学者引用


        除了所发表论文的被引用频次、期刊质量能够彰显学者的学术影响力以外,被知名学者引用也是一项学术评价的重要指标。
        当前全球学者库认定的知名学者包括:诺贝尔奖、菲尔兹奖、图灵奖等奖项获得者,多个国家的院士,全球学者库“2023全球学者学术影响力排行版”入榜的前10万学者等。

Yao,Zhang Family Health International 360被知名学者引用:74人次(黄金会员以上可以申请导出本人论文被全部知名学者引用的数据)

1. 王辰 中国 中国医学科学院 2020美国医学院院士;中国工程院院士 Characteristics, Management and In-Hospital Clinical Outcomes Among Inpatients with Acute Exacerbati..

2. Marc,Miravitlles 西班牙 Hospital Vall D'hebron Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-a..

3. Antoni,Torres 西班牙 Hospital Clinic Barcelona Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-a..

4. Christian,Mueller 瑞士 University of Basel Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-a..

5. Philipp,Schuetz 瑞士 University of BASEL Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-a..

6. Luis Lopez-Campos, Jose 西班牙 University of SEVILLE Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-a..

7. Robert J,Hancox 新西兰 University of Otago Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-a..

8. Janson, Christer 瑞典 Uppsala University Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-a..

9. Charlotte Suppli,Ulrik 丹麦 University of Copenhagen Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-a..

10. Dominguez, Jose 西班牙 Autonomous University of Barcelona Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-a..

11. Martijn A,Spruit 荷兰 Maastricht University Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-a..

12. Philipp,Schuetz 瑞士 University of BASEL One biomarker does not fit all: tailoring anti-infective therapy through utilization of procalcitoni..

13. Andrea S,Gershon 加拿大 University of Toronto Predictors of Readmission, for Patients with Chronic Obstructive Pulmonary Disease (COPD) - A System..

14. 王业明 中国 中日友好医院 Procalcitonin-guided initiation of antibiotics in AECOPD inpatients: study protocol for a multicente..

15. 曹彬 中国 中日友好医院 主任医师 Procalcitonin-guided initiation of antibiotics in AECOPD inpatients: study protocol for a multicente..

16. Tjip S,van der Werf 荷兰 University of Groningen COPD-Lower Respiratory Tract Infection Visual Analogue Score (c-LRTI-VAS) validation in stable and e..

17. James C,Hogg 加拿大 University of British Columbia Immune-Modulation in Chronic Obstructive Pulmonary Disease: Current Concepts and Future Strategies

18. Antoni,Torres 西班牙 Hospital Clinic Barcelona How may we improve clinical outcomes for patients hospitalized with acute exacerbations of chronic o..

19. Murad, Mohammad Hassan 美国 Mayo Clinic - Rochester Pharmacologic Therapies in Patients With Exacerbation of Chronic Obstructive Pulmonary Disease A Sys..

20. 邱海波 中国 东南大学 Ineffectiveness of procalcitonin-guided antibiotic therapy in severely critically ill patients: A me..

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3